Endotoxin-induced lung injury in α-galactosylceramide-sensitized mice is caused by failure of interleukin-4 production in lung natural killer T cells

Clinical and Experimental Immunology

Volumn 162, Issue 1, 2010, Pages 169-177

  Dagvadorj, J ^a   Tumurkhuu, G ^a   Naiki, Y ^a   Noman, A S M ^a   Iftakhar E Khuda, I ^a   Badamtseren, B ^a   Komatsu, T ^a   Koide, N ^a   Yoshida, T ^a   Yokochi, T ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

galactosylceramide; interferon (IFN) ; interleukin (IL) 4; lipopolysaccharide; NK T cell

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; LIVER INJURY; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CELLS, CULTURED; ENDOTOXINS; FLOW CYTOMETRY; GALACTOSYLCERAMIDES; IMMUNOBLOTTING; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-4; KILLER CELLS, NATURAL; LIVER; LUNG; LUNG INJURY; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT1 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 77956504997     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04225.x     Document Type: Article

References (38)

1. Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 2005 3 : 36 46.
2. Lien E, Means TK, Heine H et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000 105 : 497 504.
3. Ito H, Koide N, Hassan F et al. Lethal endotoxic shock using alpha-galactosylceramide sensitization as a new experimental model of septic shock. Lab Invest 2006 86 : 254 261.
4. Tumurkhuu G, Koide N, Dagvadorj J et al. The mechanism of development of acute lung injury in lethal endotoxic shock using alpha-galactosylceramide sensitization. Clin Exp Immunol 2008 152 : 182 191.
5. Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997 278 : 1626 1629.
6. Eberl G, Lees R, Smiley ST et al. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol 1999 162 : 6410 6419.
7. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005 23 : 877 900.
8. Sireci G, La Manna MP, Di Sano C et al. Pivotal advance: alpha-galactosylceramide induces protection against lipopolysaccharide-induced shock. J Leukoc Biol 2007 81 : 607 622.
9. Mednick AJ, Nosanchuk JD, Casadevall A. Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection. Infect Immun 2005 73 : 2012 2019.
10. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992 119 : 493 501.
11. Zhang XM, Morikawa A, Takahashi K et al. Localization of apoptosis (programmed cell death) in mice by administration of lipopolysaccharide. Microbiol Immunol 1994 38 : 669 671.
12. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004 114 : 1379 1388.
13. Hsu DH, Moore KW, Spits H. Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity. Int Immunol 1992 4 : 563 569.
14. Naundorf S, Schroder M, Hoflich C et al. IL-10 interferes directly with TCR-induced IFN-gamma but not IL-17 production in memory T cells. Eur J Immunol 2009 39 : 1066 1077.
15. Nguyen VT, Benveniste EN. IL-4-activated STAT-6 inhibits IFN-gamma-induced CD40 gene expression in macrophages/microglia. J Immunol 2000 165 : 6235 6243.
16. Mendiratta SK, Martin WD, Hong S et al. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997 6 : 469 477.
17. Qing Y, Costa-Pereira AP, Watling D et al. Role of tyrosine 441 of interferon-gamma receptor subunit 1 in SOCS-1-mediated attenuation of STAT1 activation. J Biol Chem 2005 280 : 1849 1853.
18. Fenner JE, Starr R, Cornish AL et al. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat Immunol 2006 7 : 33 9.
19. DiGiandomenico A, Wylezinski LS, Hawiger J. Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling. Sci Signal 2009 2 : ra37.
20. Marine JC, Topham DJ, McKay C et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 1999 98 : 609 616.
21. Alexander WS, Starr R, Fenner JE et al. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 1999 98 : 597 608.
22. Seino K, Taniguchi M. Functionally distinct NKT cell subsets and subtypes. J Exp Med 2005 202 : 1623 1626.
23. Hammond KJ, Pelikan SB, Crowe NY et al. NKT cells are phenotypically and functionally diverse. Eur J Immunol 1999 29 : 3768 3781.
24. Emoto M, Zerrahn J, Miyamoto M et al. Phenotypic characterization of CD8(+)NKT cells. Eur J Immunol 2000 30 : 2300 2311.
25. Lisbonne M, Leite-de-Moraes MC. Invariant Valpha14 NKT lymphocytes: a double-edged immuno-regulatory T cell population. Eur Cytokine Netw 2003 14 : 4 14.
26. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002 2 : 557 568.
27. Godfrey DI, Hammond KJ, Poulton LD et al. NKT cells: facts, functions and fallacies. Immunol Today 2000 21 : 573 583.
28. Lee H, Hong C, Shin J et al. The presence of CD8(+) invariant NKT cells in mice. Exp Mol Med 2009 41 : 866 872.
29. Ogawa Y, Duru EA, Ameredes BT. Role of IL-10 in the resolution of airway inflammation. Curr Mol Med 2008 8 : 437 445.
30. Bonfield TL, Konstan MW, Burfeind P et al. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995 13 : 257 261.
31. Grutz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol 2005 77 : 3 15.
32. Wormald S, Zhang JG, Krebs DL et al. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling. J Biol Chem 2006 281 : 11135 11143.
33. Fujimoto M, Naka T. Regulation of cytokine signaling by SOCS family molecules. Trends Immunol 2003 24 : 659 666.
34. Kubo M, Hanada T, Yoshimura A. Suppressors of cytokine signaling and immunity. Nat Immunol 2003 4 : 1169 1176.
35. Tan JC, Rabkin R. Suppressors of cytokine signaling in health and disease. Pediatr Nephrol 2005 20 : 567 575.
36. Cooney RN. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock 2002 17 : 83 90.
37. Ding Y, Chen D, Tarcsafalvi A et al. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J Immunol 2003 170 : 1383 1391.
38. Ding L, Linsley PS, Huang LY et al. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993 151 : 1224 1234.